Rastex: A New and Innovative Iranian Pharmaceutical Brand

A new brand from HITCO Holding is on its way to enter the specialized pharmaceutical market.

Dr. Maryam Habibi, CEO of Rasta Imen Darou, announced that Rastex, the company’s new specialty brand, has been established with a focus on local manufacturing and the use of advanced pharmaceutical formulations.

She added that the brand aims to meet the treatment needs of patients with high-quality, reliable products in the fields of cardiovascular disease and diabetes, adhering to modern pharmaceutical standards.

Dr. Habibi emphasized that Rastex represents both a commitment to domestic capabilities and a spirit of innovation within Iran’s pharmaceutical industry.

The first products under this new domestic brand will soon be introduced to the national pharmaceutical market by Rasta Imen Darou.